Mark Austin
0000-0003-4943-7265
AstraZeneca R&D Cambridge
1 paper found
Refreshing results…
Extensive sequence and structural evolution of Arginase 2 inhibitory antibodies enabled by an unbiased approach to affinity maturation
Missing publications? Search for publications with a matching author name.